Clinicopathological characteristics of cancer patients used in this study. Table S1. All primer pairs used in this study. Table S2. Clinicopathological characteristics of 196 CRC patients. Table S3. Clinicopathological characteristics of 292 GC patients. Table S4. Clinicopathological characteristics of 170 oral cancer patients. (DOCX 34 kb
Table S1. The primers and sequences for qPCR, siRNA, ChIP and RIP assays. (XLSX 12 kb
Clinical characteristics of NSCLC patients. Table S2. DNA sequences of real-time PCR primers used fo...
Table S1. Summary of overall survival analysis by univariate and multivariate COX regression analysi...
All supplementary figures associated with lncRNA OLA1P2. Figure S1. Dysregulation of genes in primar...
Table S1. Summary table. Table S2. Subgroup analysis of relative risk of gastric cancer. Table S3. S...
Table S1. Patient demographic and baseline characteristics of the study population. Table S2. Demogr...
Table S1. Clinical characteristics. Table S2. RNA-seq gene function list. Table S3. Gene function an...
Table S1. Detailed information of cohort 1 and 2 is listed. Table S2. Primers and RNA sequences used...
Detailed information of tumoral characteristics of patients and the information of metastasis. *The ...
Table S3. Sequences of siRNAs used in this study. Table S4. Sequences of primers used in this study....
Table S1. Pyrosequencing primers of the six final candidate SNPs. Table S2. Detailed result of the 7...
Patientsâ characteristics according to lost to follow-up at 3-years. Table S2. Distribution of non...
Figure S1. Correlation of CYR61 expression of CRC tissues in IHC and clinicopathological parameters....
Table S1. Number of patients with comorbidity and medications among stage I–III and ICD10 codes of c...
GTCpFE inhibits cytokine-induced NFκB target gene expression in breast cancer cells. MCF-7 cells wer...
Table S1. The primers and sequences for qPCR, siRNA, ChIP and RIP assays. (XLSX 12 kb
Clinical characteristics of NSCLC patients. Table S2. DNA sequences of real-time PCR primers used fo...
Table S1. Summary of overall survival analysis by univariate and multivariate COX regression analysi...
All supplementary figures associated with lncRNA OLA1P2. Figure S1. Dysregulation of genes in primar...
Table S1. Summary table. Table S2. Subgroup analysis of relative risk of gastric cancer. Table S3. S...
Table S1. Patient demographic and baseline characteristics of the study population. Table S2. Demogr...
Table S1. Clinical characteristics. Table S2. RNA-seq gene function list. Table S3. Gene function an...
Table S1. Detailed information of cohort 1 and 2 is listed. Table S2. Primers and RNA sequences used...
Detailed information of tumoral characteristics of patients and the information of metastasis. *The ...
Table S3. Sequences of siRNAs used in this study. Table S4. Sequences of primers used in this study....
Table S1. Pyrosequencing primers of the six final candidate SNPs. Table S2. Detailed result of the 7...
Patientsâ characteristics according to lost to follow-up at 3-years. Table S2. Distribution of non...
Figure S1. Correlation of CYR61 expression of CRC tissues in IHC and clinicopathological parameters....
Table S1. Number of patients with comorbidity and medications among stage I–III and ICD10 codes of c...
GTCpFE inhibits cytokine-induced NFκB target gene expression in breast cancer cells. MCF-7 cells wer...
Table S1. The primers and sequences for qPCR, siRNA, ChIP and RIP assays. (XLSX 12 kb
Clinical characteristics of NSCLC patients. Table S2. DNA sequences of real-time PCR primers used fo...
Table S1. Summary of overall survival analysis by univariate and multivariate COX regression analysi...